Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02296801
Title A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | CAN


No variant requirements are available.